Canada awaits formal HTA (health technology assessment)
This article was originally published in Clinica
The Canadian medical device industry sees the introduction of a formal health technology assessment (HTA) system as increasingly inevitable.
You may also be interested in...
Fresenius Kabi has reported sales ahead by 6% in 2019, as growth in emerging markets helped to offset a subdued increase in North America. Meanwhile, the firm has pushed back financial expectations for its biosimilars by a year.
Fresenius Kabi and Vifor Pharma have agreed to create a joint venture in China for intravenous iron products.
The value of rare disease research must not be overlooked as the drive to diagnose and contain coronavirus mounts.